The SRF launched the CONQUER Registry in 2018 through a collaborative effort with the largest scleroderma centers in the U.S. The goal of this registry is the enrollment of thousands of patients from around the country in this first-of-its-kind nationwide longitudinal patient registry. The data generated through CONQUER will allow researchers and clinicians to learn about all forms of scleroderma so that they can advance research and discovery.
Hear from one of CONQUER’s principal investigators, Dr. Lorinda Chung of Stanford University, about why patient participation in the registry is essential for improving care and developing more effective, personalized therapies for scleroderma patients.
